What is the appropriate workup for fever of unknown origin?

Workup of Fever of Unknown Origin

Begin with a chest radiograph for all patients with FUO, followed by comprehensive laboratory testing including blood cultures (at least two sets from different sites), urinalysis with culture, complete blood count, inflammatory markers (ESR and CRP), and liver enzymes; if these initial tests are unrevealing, proceed directly to FDG-PET/CT as the advanced imaging modality of choice. 1, 2, 3

Initial Clinical Evaluation

Essential History Components

• Geographic location and travel history to identify region-specific infectious exposures 4
• Epidemiologic risk factors including occupational exposures, animal contacts, and sick contacts 4
• Medication history to exclude drug-induced fever 5
• Immunization status and immunocompromised conditions 5

Physical Examination Focus

• Daily comprehensive examinations looking for new localizing signs, as findings may evolve over time 6
• Temporal artery palpation for tenderness suggesting giant cell arteritis 5
• Lymph node examination for adenopathy suggesting lymphoma or infection 5
• Cardiac auscultation for new murmurs indicating endocarditis 1

Initial Diagnostic Testing

Mandatory First-Line Tests

• Chest radiograph - recommended for all patients developing fever, as it may reveal occult pneumonia, malignancy, or tuberculosis 1
• At least two sets of blood cultures (ideally 60 mL total) drawn sequentially from different anatomical sites without time intervals between them 1
• Complete blood count with differential to assess for leukemia, infection patterns, or cytopenias 5, 7
• Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) - elevated levels support inflammatory/infectious etiology and guide need for advanced imaging 5, 7
• Comprehensive metabolic panel including liver enzymes, as transaminase elevation may indicate hepatobiliary pathology 1, 7
• Urinalysis and urine culture to exclude urinary tract infection 5, 7

Second-Line Laboratory Testing

• Lactate dehydrogenase (LDH) - elevated in lymphoma and hemolytic processes 7
• Creatine kinase - elevated in inflammatory myopathies 7
• Rheumatoid factor and antinuclear antibodies to screen for autoimmune conditions 7
• HIV testing - essential as HIV-related FUO represents a distinct diagnostic category 7, 8
• Region-specific serologies (cytomegalovirus, Epstein-Barr virus, tuberculosis testing) based on epidemiologic clues 7

Advanced Imaging Strategy

When Initial Workup is Unrevealing

FDG-PET/CT is the advanced imaging modality of choice when initial diagnostic tests fail to establish an etiology 1, 2, 3

FDG-PET/CT Performance Characteristics

• Sensitivity: 80-100% in identifying the source of FUO 1
• Specificity: 66.7-79.2% for localizing inflammatory, infectious, or neoplastic foci 1
• Diagnostic yield: 48% in pediatric studies, with treatment modifications in 53% of cases 1
• Most commonly identifies: endocarditis (11%), systemic inflammatory conditions (5%), inflammatory bowel disease (5%), and occult malignancies 1

Advantages of FDG-PET/CT

• Whole-body imaging allows detection of unexpected sites of pathology 2, 3
• Guides tissue biopsy by identifying hypermetabolic lesions amenable to sampling 5, 2
• Detects glycolytically active cells representing inflammation, infection, or neoplasia 3

Situation-Specific Imaging

Post-Surgical Patients

CT of chest, abdomen, and pelvis with IV contrast is recommended (in collaboration with surgical service) if etiology not identified by initial workup, as it effectively identifies abscesses, anastomotic leaks, and collections 1

Patients with Abdominal Signs

Formal bedside diagnostic ultrasound of abdomen for patients with abdominal symptoms, abnormal liver enzymes, or recent abdominal surgery 1

Avoid routine abdominal ultrasound in patients without abdominal signs, symptoms, liver function abnormalities, or recent surgery 1

Patients with Abnormal Chest Radiograph

Thoracic bedside ultrasound when expertise available to identify pleural effusions and parenchymal pathology more reliably than radiography alone 1

Invasive Diagnostic Procedures

When Noninvasive Testing is Unrevealing

Tissue biopsy has the highest diagnostic yield among invasive procedures and should be pursued when imaging identifies a target 5

Biopsy Site Selection (in order of consideration)

• Liver biopsy - high yield for granulomatous diseases, infiltrative malignancies 5
• Lymph node biopsy - when adenopathy present, excisional preferred over needle 5
• Temporal artery biopsy - for patients >50 years with elevated ESR suggesting giant cell arteritis 5
• Bone marrow biopsy - useful for hematologic malignancies, granulomatous diseases, hemophagocytic syndromes 5

Special Populations

Neutropenic Patients

• Chest CT (with or without IV contrast) strongly recommended for prolonged febrile neutropenia (>96 hours) when concern for invasive fungal disease exists 1
• Sensitivity 79%, specificity 85% for detecting invasive pulmonary aspergillosis 1
• Avoid empiric abdominal/pelvic CT unless localizing signs present; focus on chest imaging 1

Critically Ill ICU Patients

• Central venous catheter cultures from at least two lumens simultaneously with peripheral blood cultures to calculate differential time to positivity 1
• Viral nucleic acid amplification testing for patients with respiratory symptoms 1
• Replace urinary catheter before obtaining cultures if urinary tract infection suspected 1

Common Pitfalls to Avoid

Testing Pitfalls

• Avoid empiric antimicrobial therapy except in neutropenic, immunocompromised, or critically ill patients, as it obscures diagnosis without improving outcomes 5, 7
• Avoid empiric corticosteroids in absence of diagnosis, especially early in workup, as they mask inflammatory conditions and infections 9
• Do not use rapid molecular blood tests without concomitant blood cultures, as they have limited utility alone 1
• Avoid non-clue-based imaging early in workup, as it is inefficient and potentially misleading 6

Imaging Pitfalls

• Do not perform WBC scans - insufficient evidence supports their use in FUO 1
• Avoid FDG-PET/MRI - insufficient data to support its use despite theoretical advantages 1
• Do not order fluoride PET/CT - no evidence supports its use in FUO 1

Diagnostic Outcomes

Expected Resolution Patterns

• Up to 75% of cases resolve spontaneously without definitive diagnosis in adults 5
• Most cases represent uncommon presentations of common diseases rather than rare conditions 5, 7
• Undiagnosed FUO generally has favorable prognosis with spontaneous fever remission in majority of cases 9

Diagnostic Categories (in order of frequency)

1. Infections - most common in quantitative criteria studies 10
2. Noninfectious inflammatory diseases - including autoimmune conditions 5, 7
3. Malignancies - particularly lymphomas and leukemias 5, 7
4. Miscellaneous - including venous thromboembolism, thyroiditis, drug fever 5, 7